- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Remicade Biosimilar market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Remicade Biosimilar market. Detailed analysis of key players, along with key growth strategies adopted by Remicade Biosimilar industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Biocon
Synthon Pharmaceuticals
Celltrion
Hospira
Novartis (Sandoz)
Merck Serono (Merck Group)
Genentech (Roche Group)
LG Life Sciences
By Type:
100mg/10ml
500mg/50ml
By End-User:
Blood Disorders
Oncology Diseases
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Remicade Biosimilar Market
-
1.3 Market Segment by Type
-
1.3.1 China Remicade Biosimilar Market Size and Growth Rate of 100mg/10ml from 2016 to 2027
-
1.3.2 China Remicade Biosimilar Market Size and Growth Rate of 500mg/50ml from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Remicade Biosimilar Market Size and Growth Rate of Blood Disorders from 2016 to 2027
-
1.4.2 China Remicade Biosimilar Market Size and Growth Rate of Oncology Diseases from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Remicade Biosimilar Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Remicade Biosimilar by Major Types
-
3.4.1 Market Size and Growth Rate of 100mg/10ml
-
3.4.2 Market Size and Growth Rate of 500mg/50ml
4 Segmentation of Remicade Biosimilar Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Remicade Biosimilar by Major End-Users
-
4.4.1 Market Size and Growth Rate of Remicade Biosimilar in Blood Disorders
-
4.4.2 Market Size and Growth Rate of Remicade Biosimilar in Oncology Diseases
5 Market Analysis by Regions
-
5.1 China Remicade Biosimilar Production Analysis by Regions
-
5.2 China Remicade Biosimilar Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Remicade Biosimilar Landscape Analysis
-
6.1 North China Remicade Biosimilar Landscape Analysis by Major Types
-
6.2 North China Remicade Biosimilar Landscape Analysis by Major End-Users
7 Central China Remicade Biosimilar Landscape Analysis
-
7.1 Central China Remicade Biosimilar Landscape Analysis by Major Types
-
7.2 Central China Remicade Biosimilar Landscape Analysis by Major End-Users
8 South China Remicade Biosimilar Landscape Analysis
-
8.1 South China Remicade Biosimilar Landscape Analysis by Major Types
-
8.2 South China Remicade Biosimilar Landscape Analysis by Major End-Users
9 East China Remicade Biosimilar Landscape Analysis
-
9.1 East China Remicade Biosimilar Landscape Analysis by Major Types
-
9.2 East China Remicade Biosimilar Landscape Analysis by Major End-Users
10 Northeast China Remicade Biosimilar Landscape Analysis
-
10.1 Northeast China Remicade Biosimilar Landscape Analysis by Major Types
-
10.2 Northeast China Remicade Biosimilar Landscape Analysis by Major End-Users
11 Southwest China Remicade Biosimilar Landscape Analysis
-
11.1 Southwest China Remicade Biosimilar Landscape Analysis by Major Types
-
11.2 Southwest China Remicade Biosimilar Landscape Analysis by Major End-Users
12 Northwest China Remicade Biosimilar Landscape Analysis
-
12.1 Northwest China Remicade Biosimilar Landscape Analysis by Major Types
-
12.2 Northwest China Remicade Biosimilar Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Biocon
-
13.1.1 Biocon Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Synthon Pharmaceuticals
-
13.2.1 Synthon Pharmaceuticals Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Celltrion
-
13.3.1 Celltrion Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Hospira
-
13.4.1 Hospira Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Novartis (Sandoz)
-
13.5.1 Novartis (Sandoz) Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Merck Serono (Merck Group)
-
13.6.1 Merck Serono (Merck Group) Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Genentech (Roche Group)
-
13.7.1 Genentech (Roche Group) Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 LG Life Sciences
-
13.8.1 LG Life Sciences Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Remicade Biosimilar Market Size and Growth Rate of 100mg/10ml from 2016 to 2027
-
Figure China Remicade Biosimilar Market Size and Growth Rate of 500mg/50ml from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Remicade Biosimilar Market Size and Growth Rate of Blood Disorders from 2016 to 2027
-
Figure China Remicade Biosimilar Market Size and Growth Rate of Oncology Diseases from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Remicade Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Remicade Biosimilar Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Remicade Biosimilar
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Remicade Biosimilar by Different Types from 2016 to 2027
-
Table Consumption Share of Remicade Biosimilar by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 100mg/10ml
-
Figure Market Size and Growth Rate of 500mg/50ml
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Remicade Biosimilar by Different End-Users from 2016 to 2027
-
Table Consumption Share of Remicade Biosimilar by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Blood Disorders
-
Figure Market Size and Growth Rate of Oncology Diseases
-
Table China Remicade Biosimilar Production by Regions
-
Table China Remicade Biosimilar Production Share by Regions
-
Figure China Remicade Biosimilar Production Share by Regions in 2016
-
Figure China Remicade Biosimilar Production Share by Regions in 2021
-
Figure China Remicade Biosimilar Production Share by Regions in 2027
-
Table China Remicade Biosimilar Consumption by Regions
-
Table China Remicade Biosimilar Consumption Share by Regions
-
Figure China Remicade Biosimilar Consumption Share by Regions in 2016
-
Figure China Remicade Biosimilar Consumption Share by Regions in 2021
-
Figure China Remicade Biosimilar Consumption Share by Regions in 2027
-
Table North China Remicade Biosimilar Consumption by Types from 2016 to 2027
-
Table North China Remicade Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure North China Remicade Biosimilar Consumption Share by Types in 2016
-
Figure North China Remicade Biosimilar Consumption Share by Types in 2021
-
Figure North China Remicade Biosimilar Consumption Share by Types in 2027
-
Table North China Remicade Biosimilar Consumption by End-Users from 2016 to 2027
-
Table North China Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure North China Remicade Biosimilar Consumption Share by End-Users in 2016
-
Figure North China Remicade Biosimilar Consumption Share by End-Users in 2021
-
Figure North China Remicade Biosimilar Consumption Share by End-Users in 2027
-
Table Central China Remicade Biosimilar Consumption by Types from 2016 to 2027
-
Table Central China Remicade Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Central China Remicade Biosimilar Consumption Share by Types in 2016
-
Figure Central China Remicade Biosimilar Consumption Share by Types in 2021
-
Figure Central China Remicade Biosimilar Consumption Share by Types in 2027
-
Table Central China Remicade Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Central China Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Remicade Biosimilar Consumption Share by End-Users in 2016
-
Figure Central China Remicade Biosimilar Consumption Share by End-Users in 2021
-
Figure Central China Remicade Biosimilar Consumption Share by End-Users in 2027
-
Table South China Remicade Biosimilar Consumption by Types from 2016 to 2027
-
Table South China Remicade Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure South China Remicade Biosimilar Consumption Share by Types in 2016
-
Figure South China Remicade Biosimilar Consumption Share by Types in 2021
-
Figure South China Remicade Biosimilar Consumption Share by Types in 2027
-
Table South China Remicade Biosimilar Consumption by End-Users from 2016 to 2027
-
Table South China Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure South China Remicade Biosimilar Consumption Share by End-Users in 2016
-
Figure South China Remicade Biosimilar Consumption Share by End-Users in 2021
-
Figure South China Remicade Biosimilar Consumption Share by End-Users in 2027
-
Table East China Remicade Biosimilar Consumption by Types from 2016 to 2027
-
Table East China Remicade Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure East China Remicade Biosimilar Consumption Share by Types in 2016
-
Figure East China Remicade Biosimilar Consumption Share by Types in 2021
-
Figure East China Remicade Biosimilar Consumption Share by Types in 2027
-
Table East China Remicade Biosimilar Consumption by End-Users from 2016 to 2027
-
Table East China Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure East China Remicade Biosimilar Consumption Share by End-Users in 2016
-
Figure East China Remicade Biosimilar Consumption Share by End-Users in 2021
-
Figure East China Remicade Biosimilar Consumption Share by End-Users in 2027
-
Table Northeast China Remicade Biosimilar Consumption by Types from 2016 to 2027
-
Table Northeast China Remicade Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Remicade Biosimilar Consumption Share by Types in 2016
-
Figure Northeast China Remicade Biosimilar Consumption Share by Types in 2021
-
Figure Northeast China Remicade Biosimilar Consumption Share by Types in 2027
-
Table Northeast China Remicade Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Northeast China Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Remicade Biosimilar Consumption Share by End-Users in 2016
-
Figure Northeast China Remicade Biosimilar Consumption Share by End-Users in 2021
-
Figure Northeast China Remicade Biosimilar Consumption Share by End-Users in 2027
-
Table Southwest China Remicade Biosimilar Consumption by Types from 2016 to 2027
-
Table Southwest China Remicade Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Remicade Biosimilar Consumption Share by Types in 2016
-
Figure Southwest China Remicade Biosimilar Consumption Share by Types in 2021
-
Figure Southwest China Remicade Biosimilar Consumption Share by Types in 2027
-
Table Southwest China Remicade Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Southwest China Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Remicade Biosimilar Consumption Share by End-Users in 2016
-
Figure Southwest China Remicade Biosimilar Consumption Share by End-Users in 2021
-
Figure Southwest China Remicade Biosimilar Consumption Share by End-Users in 2027
-
Table Northwest China Remicade Biosimilar Consumption by Types from 2016 to 2027
-
Table Northwest China Remicade Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Remicade Biosimilar Consumption Share by Types in 2016
-
Figure Northwest China Remicade Biosimilar Consumption Share by Types in 2021
-
Figure Northwest China Remicade Biosimilar Consumption Share by Types in 2027
-
Table Northwest China Remicade Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Northwest China Remicade Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Remicade Biosimilar Consumption Share by End-Users in 2016
-
Figure Northwest China Remicade Biosimilar Consumption Share by End-Users in 2021
-
Figure Northwest China Remicade Biosimilar Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
Table Company Profile and Development Status of Synthon Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthon Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Synthon Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Synthon Pharmaceuticals
-
Table Product and Service Introduction of Synthon Pharmaceuticals
-
Table Company Profile and Development Status of Celltrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
-
Figure Sales and Growth Rate Analysis of Celltrion
-
Figure Revenue and Market Share Analysis of Celltrion
-
Table Product and Service Introduction of Celltrion
-
Table Company Profile and Development Status of Hospira
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira
-
Figure Sales and Growth Rate Analysis of Hospira
-
Figure Revenue and Market Share Analysis of Hospira
-
Table Product and Service Introduction of Hospira
-
Table Company Profile and Development Status of Novartis (Sandoz)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis (Sandoz)
-
Figure Sales and Growth Rate Analysis of Novartis (Sandoz)
-
Figure Revenue and Market Share Analysis of Novartis (Sandoz)
-
Table Product and Service Introduction of Novartis (Sandoz)
-
Table Company Profile and Development Status of Merck Serono (Merck Group)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Serono (Merck Group)
-
Figure Sales and Growth Rate Analysis of Merck Serono (Merck Group)
-
Figure Revenue and Market Share Analysis of Merck Serono (Merck Group)
-
Table Product and Service Introduction of Merck Serono (Merck Group)
-
Table Company Profile and Development Status of Genentech (Roche Group)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech (Roche Group)
-
Figure Sales and Growth Rate Analysis of Genentech (Roche Group)
-
Figure Revenue and Market Share Analysis of Genentech (Roche Group)
-
Table Product and Service Introduction of Genentech (Roche Group)
-
Table Company Profile and Development Status of LG Life Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LG Life Sciences
-
Figure Sales and Growth Rate Analysis of LG Life Sciences
-
Figure Revenue and Market Share Analysis of LG Life Sciences
-
Table Product and Service Introduction of LG Life Sciences
-